<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00774969</url>
  </required_header>
  <id_info>
    <org_study_id>MET/PK/01</org_study_id>
    <secondary_id>EudraCT/IND 2007003173-68</secondary_id>
    <nct_id>NCT00774969</nct_id>
  </id_info>
  <brief_title>Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease</brief_title>
  <official_title>Phase 1 Study to Evaluate the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri-Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>S.L.A. Pharma AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>S.L.A. Pharma AG</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the blood levels of Metronidazole after application
      to the peri anal area after a single dose and 6 or 7 days application.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
  </study_design_info>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Perianal Crohns'</condition>
  <arm_group>
    <arm_group_label>All</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 patients with Perianal Crohn's Disease and 10 healthy Volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metronidazole</intervention_name>
    <description>Metronidazole 10% ointment three times a day 7 days</description>
    <arm_group_label>All</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patient group:

          -  Male and female patients with Crohn's disease (diagnosed by radiology, endoscopy and
             pathology), with anorectal involvement.

          -  Aged 18-65 years.

          -  Have had perianal symptoms for longer than 2 months

          -  Have a score of 5 or above in the Perianal Crohn's Disease Activity Index (PCDAI)

          -  Have a score of 1 or above on the 'Type of perianal disease' assessment of the PCDAI

          -  Subjects can be on concomitant medication. Acceptable regimens are:

               -  Aminosalicylates at a dosage that has been stable for more than 4 weeks before
                  screening;Infliximab on a stable infusion regimen;

               -  Oral corticosteroids &lt;40mg per day; Methotrexate, provided that dosage has been
                  stable for more than 4 weeks; azathioprine or mercaptopurine at a dosage that has
                  been stable for more than 8 weeks;

               -  Antibiotics at a dosage that has been stable for 4 weeks but excluding
                  metronidazole.

               -  Cyclosporin on a stable dose for more than 4 weeks.

          -  If patients have setons these must have been in place for at least 4 weeks prior to
             screening.

          -  If female, the subject must not be lactating and must be (a) post-menopausal, (b)
             surgically sterilised, or (c) have a negative pregnancy test result prior to entry
             into the study and will use double-barrier methods of contraception (two separate
             methods of birth control, one of which may include oral contraception) for the
             duration of the study.

          -  Must have provided written informed consent to participate.

        Healthy volunteer group:

          -  They have had surgery to the anus or rectum in the past 4 weeks.

          -  Have a history of inflammatory bowel disease.

          -  Allergic to metronidazole.

          -  Are taking any prohibited medication.

          -  Not prepared to refrain from drinking alcohol during the course of the study.

          -  Deemed mentally incompetent.

          -  Considered by their physician unlikely to be able to comply with the protocol.

          -  Has donated blood within the past 3 months.

          -  Taken part in an experimental drug study in the preceding three months.

        Exclusion Criteria:

        Patient group:

          -  They have had surgery to the anus or rectum in the past 4 weeks.

          -  They have a perianal abscess requiring incision and drainage.

          -  They have a stoma of less than 6 months duration.

          -  Allergic to metronidazole.

          -  Are taking any prohibited medication.

          -  Not prepared to refrain from drinking alcohol during the course of the study.

          -  Deemed mentally incompetent.

          -  Considered by their physician unlikely to be able to comply with the protocol.

          -  Has donated blood within the past 3 months.

          -  Taken part in an experimental drug study in the preceding three months.

          -  Has donated blood within the past 3 months.

          -  Taken part in an experimental drug study in the preceding three months.

        Healthy volunteer group:

          -  They have had surgery to the anus or rectum in the past 4 weeks.

          -  Have a history of inflammatory bowel disease.

          -  Allergic to metronidazole.

          -  Are taking any prohibited medication.

          -  Not prepared to refrain from drinking alcohol during the course of the study.

          -  Deemed mentally incompetent.

          -  Considered by their physician unlikely to be able to comply with the protocol.

          -  Has donated blood within the past 3 months.

          -  Taken part in an experimental drug study in the preceding three months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher J Jordan, BSC</last_name>
    <role>Study Director</role>
    <affiliation>SLA Pharma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sainsbury Wing, St Marks &amp; Northwick Park Hospitals, Watford Road</name>
      <address>
        <city>Harrow</city>
        <zip>HA1 3UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2008</study_first_submitted>
  <study_first_submitted_qc>October 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2008</study_first_posted>
  <last_update_submitted>October 16, 2008</last_update_submitted>
  <last_update_submitted_qc>October 16, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 17, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metronidazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

